53 related articles for article (PubMed ID: 38532470)
21. piR-823 inhibits cell apoptosis via modulating mitophagy by binding to PINK1 in colorectal cancer.
Wang S; Jiang X; Xie X; Yin J; Zhang J; Liu T; Chen S; Wang Y; Zhou X; Wang Y; Cui R; Jiang H
Cell Death Dis; 2022 May; 13(5):465. PubMed ID: 35581181
[TBL] [Abstract][Full Text] [Related]
22. Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis.
Homayoonfal M; Asemi Z; Yousefi B
Cell Mol Biol Lett; 2022 Mar; 27(1):21. PubMed ID: 35236304
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy Side-Effects: Not All DNA Damage Is Equal.
van den Boogaard WMC; Komninos DSJ; Vermeij WP
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158895
[TBL] [Abstract][Full Text] [Related]
24. Global colorectal cancer burden in 2020 and projections to 2040.
Xi Y; Xu P
Transl Oncol; 2021 Oct; 14(10):101174. PubMed ID: 34243011
[TBL] [Abstract][Full Text] [Related]
25. Thymoquinone, as a Novel Therapeutic Candidate of Cancers.
Almajali B; Al-Jamal HAN; Taib WRW; Ismail I; Johan MF; Doolaanea AA; Ibrahim WN
Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33923474
[TBL] [Abstract][Full Text] [Related]
26. Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds.
Haque A; Brazeau D; Amin AR
Eur J Cancer; 2021 May; 149():165-183. PubMed ID: 33865202
[TBL] [Abstract][Full Text] [Related]
27. Autophagy in tumour immunity and therapy.
Xia H; Green DR; Zou W
Nat Rev Cancer; 2021 May; 21(5):281-297. PubMed ID: 33758415
[TBL] [Abstract][Full Text] [Related]
28. Thymoquinone inhibited vasculogenic capacity and promoted mesenchymal-epithelial transition of human breast cancer stem cells.
Haiaty S; Rashidi MR; Akbarzadeh M; Bazmani A; Mostafazadeh M; Nikanfar S; Zibaei Z; Rahbarghazi R; Nouri M
BMC Complement Med Ther; 2021 Mar; 21(1):83. PubMed ID: 33663486
[TBL] [Abstract][Full Text] [Related]
29. Targeting the Wnt/β-catenin signaling pathway in cancer.
Zhang Y; Wang X
J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
[TBL] [Abstract][Full Text] [Related]
30. Interplay Between Autophagy and Wnt/β-Catenin Signaling in Cancer: Therapeutic Potential Through Drug Repositioning.
Pérez-Plasencia C; López-Urrutia E; García-Castillo V; Trujano-Camacho S; López-Camarillo C; Campos-Parra AD
Front Oncol; 2020; 10():1037. PubMed ID: 33014767
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of Multidrug Resistance in Cancer Chemotherapy.
Bukowski K; Kciuk M; Kontek R
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370233
[TBL] [Abstract][Full Text] [Related]
32. Anticancer potential of emodin.
Hsu SC; Chung JG
Biomedicine (Taipei); 2012 Sep; 2(3):108-116. PubMed ID: 32289000
[TBL] [Abstract][Full Text] [Related]
33. Autophagic flux modulation by Wnt/β-catenin pathway inhibition in hepatocellular carcinoma.
Turcios L; Chacon E; Garcia C; Eman P; Cornea V; Jiang J; Spear B; Liu C; Watt DS; Marti F; Gedaly R
PLoS One; 2019; 14(2):e0212538. PubMed ID: 30794613
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic Potential and Pharmaceutical Development of Thymoquinone: A Multitargeted Molecule of Natural Origin.
Goyal SN; Prajapati CP; Gore PR; Patil CR; Mahajan UB; Sharma C; Talla SP; Ojha SK
Front Pharmacol; 2017; 8():656. PubMed ID: 28983249
[TBL] [Abstract][Full Text] [Related]
35. Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer.
Zhang L; Shay JW
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28423402
[TBL] [Abstract][Full Text] [Related]
36. Thymoquinone chemosensitizes colon cancer cells through inhibition of NF-κB.
Zhang L; Bai Y; Yang Y
Oncol Lett; 2016 Oct; 12(4):2840-2845. PubMed ID: 27698868
[TBL] [Abstract][Full Text] [Related]
37. Autophagy in colorectal cancer: An important switch from physiology to pathology.
Burada F; Nicoli ER; Ciurea ME; Uscatu DC; Ioana M; Gheonea DI
World J Gastrointest Oncol; 2015 Nov; 7(11):271-84. PubMed ID: 26600927
[TBL] [Abstract][Full Text] [Related]
38. Thymoquinone induces caspase-independent, autophagic cell death in CPT-11-resistant lovo colon cancer via mitochondrial dysfunction and activation of JNK and p38.
Chen MC; Lee NH; Hsu HH; Ho TJ; Tu CC; Hsieh DJ; Lin YM; Chen LM; Kuo WW; Huang CY
J Agric Food Chem; 2015 Feb; 63(5):1540-6. PubMed ID: 25611974
[TBL] [Abstract][Full Text] [Related]
39. Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer.
Mu GG; Zhang LL; Li HY; Liao Y; Yu HG
Dig Dis Sci; 2015 Apr; 60(4):1067-80. PubMed ID: 25344906
[TBL] [Abstract][Full Text] [Related]
40. Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K-AKT pathway.
Dirican A; Atmaca H; Bozkurt E; Erten C; Karaca B; Uslu R
Clin Transl Oncol; 2015 Feb; 17(2):145-51. PubMed ID: 25060568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
